U.S. President Donald Trump speaks at the Oval Office of the White House, in Washington, D.C., June 3, 2026. Image@REUTERS/Kevin Lamarque
An Ebola outbreak that has already claimed 267 lives and infected more than 1,000 people in Central Africa, generating the largest number of confirmed cases within the first month of any episode of the disease, the World Health Organisation said, has forced Washington into one of its most expensive health engagements on the continent in years.
The Trump administration submitted a request to Congress on Wednesday for more than $1.4 billion in emergency Ebola funding, tucked inside a broader supplemental spending package that also sought $87.6 billion to address urgent needs related to the Iran war and $11.1 billion in farm aid. The Ebola component alone represents a sharp escalation from Washington, coming even as the administration has overseen deep cuts to overseas health assistance.
“This funding is critical to protect Americans, and stop the spread to the United States,” the White House said.
The bulk of the Ebola request, $800 million, is directed at humanitarian crisis response, covering medical supplies, treatment operations, contact tracing, a regional logistics network, infection-control measures and the construction of a quarantine centre in Kenya for Americans exposed to the virus. A further $500 million targets global health security, financing disease surveillance systems, laboratory capacity, cross-border coordination and potential partnerships with multilateral institutions and private-sector organisations. An additional $90 million has been set aside for diplomatic operations, including the evacuation and medical transport of infected U.S. citizens.
The request does not exist in a political vacuum. Congressional aides said the request could run into problems in Congress, where lawmakers, including some of President Donald Trump’s fellow Republicans, are unhappy that his administration has been refusing to spend money allocated for foreign assistance, including medical care, around the world. Critics have long argued that Washington’s gutting of the U.S. Agency for International Development and African public health partnerships weakened the very preparedness infrastructure now being called upon.
U.S. officials have also asked European counterparts to implement tougher travel measures and contribute more to the Ebola response, expressing frustration with the lack of engagement from European governments.
The urgency behind the request has been amplified by the outbreak’s spread beyond Africa. A doctor who recently returned from a humanitarian mission in the Democratic Republic of Congo tested positive for Ebola in France, marking the European country’s first confirmed case linked to the outbreak. The development has rattled public health authorities and underscored warnings that the virus is no longer a purely regional concern.
Congo’s outbreak is linked to the rare Bundibugyo strain of the virus. The two largest previous Ebola outbreaks occurred in West Africa, in Guinea, Sierra Leone and Liberia between 2014 and 2016 and in Congo in 2018.
The U.S. had already been ramping up its financial commitment before the latest congressional request. On June 18, the U.S. Centers for Disease Control and Prevention said it would make $107 million in emergency funding available to strengthen its domestic and international Ebola response, warning the outbreak could be the worst on record. Washington had also committed over $212 million to containment operations in the DRC and Uganda, and provided doses of an experimental antibody drug for use in clinical trials, a shift from its earlier position of making the treatment available only to Americans.
In May, the U.S. banned non-citizens who had travelled to the DRC, Uganda or South Sudan in recent weeks from entering the country. The ban was later extended by the CDC to green card holders who had been in those countries in the previous 21 days.
The $1.4 billion proposal is the clearest signal yet that even an administration defined by its retreat from global health engagement views a fast-moving, cross-border pathogen as a matter of national security, one that ultimately demands dollars, not just distance.
By: Andrews Kwesi Yeboah